Capricor Therapeutics (CAPR) Cash & Equivalents Growth (3y) (2013 - 2026)
Capricor Therapeutics (CAPR) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
24.73% |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
115.01% |
| Date | Value |
|---|
| Mar 31, 2026 |
115.01% |
| Dec 31, 2025 |
210.63% |
| Sep 30, 2025 |
32.36% |
| Jun 30, 2025 |
12.34% |
| Mar 31, 2025 |
-20.97% |
| Dec 31, 2024 |
-31.35% |
| Sep 30, 2024 |
18.78% |
| Jun 30, 2024 |
-34.52% |
| Mar 31, 2024 |
-47.07% |
| Dec 31, 2023 |
-23.40% |
| Sep 30, 2023 |
-36.63% |
| Jun 30, 2023 |
-35.26% |
| Mar 31, 2023 |
-7.08% |
| Dec 31, 2022 |
35.04% |
| Sep 30, 2022 |
7.21% |
| Jun 30, 2022 |
40.66% |
| Mar 31, 2022 |
101.12% |
| Dec 31, 2021 |
101.57% |
| Sep 30, 2021 |
359.07% |
| Jun 30, 2021 |
81.78% |
